Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $572.80 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $216.91 | 11 | $0 (2023) |
| ABBVIE INC. | $165.35 | 10 | $0 (2024) |
| Lilly USA, LLC | $78.83 | 5 | $0 (2023) |
| PFIZER INC. | $53.94 | 3 | $0 (2023) |
| Boston Scientific Corporation | $23.09 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $17.63 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $17.05 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31.86 | 2 | ABBVIE INC. ($31.86) |
| 2023 | $201.83 | 11 | ABBVIE INC. ($85.34) |
| 2022 | $246.85 | 14 | Novo Nordisk Inc ($78.38) |
| 2021 | $92.26 | 5 | Novo Nordisk Inc ($92.26) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Obesity | ||||||
| 04/05/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: VACCINES | ||||||
| 03/13/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/10/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Obesity | ||||||
| 03/07/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/04/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: General - Pain Management_NMD | ||||||
| 02/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Diabetes | ||||||
| 01/23/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Diabetes | ||||||
| 10/24/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 09/19/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Obesity | ||||||
| 08/30/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Diabetes | ||||||
| 08/15/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Diabetes | ||||||
| 08/04/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: VACCINES | ||||||
| 06/27/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Diabetes | ||||||
| 04/08/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: VACCINES | ||||||
| 04/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Diabetes | ||||||
| 03/28/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 336 | 418 | $53,241 | $16,224 |
| 2022 | 6 | 260 | 316 | $31,831 | $12,095 |
| 2021 | 5 | 137 | 155 | $91,431 | $7,426 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 174 | 204 | $25,897 | $9,602 | 37.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 26 | 52 | $11,066 | $2,251 | 20.3% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 42 | 52 | $5,958 | $1,138 | 19.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 13 | 13 | $1,300 | $875.42 | 67.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $2,275 | $853.95 | 37.5% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 21 | 21 | $2,687 | $521.68 | 19.4% |
| 73564 | X-ray of knee, 4 or more views | Office | 2023 | 13 | 17 | $2,146 | $421.57 | 19.6% |
| 77073 | X-ray for bone length assessment | Office | 2023 | 17 | 17 | $1,622 | $390.98 | 24.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 17 | 29 | $290.00 | $169.93 | 58.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 187 | $22,440 | $9,028 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 21 | $3,591 | $1,407 | 39.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 43 | 46 | $4,600 | $1,405 | 30.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 25 | 27 | $675.00 | $207.57 | 30.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 18 | 21 | $315.00 | $46.57 | 14.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 14 | 14 | $210.00 | $1.09 | 0.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 79 | 94 | $11,918 | $5,176 | 43.4% |
| 27447 | Repair of knee joint, lower or upper part of joint, inside and outside area | Facility | 2021 | 12 | 12 | $77,728 | $1,564 | 2.0% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 14 | 14 | $1,050 | $494.62 | 47.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 18 | 21 | $525.00 | $189.41 | 36.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 14 | 14 | $210.00 | $1.60 | 0.8% |
About Chelsea Shannon, FNP-BC
Chelsea Shannon, FNP-BC is a Family healthcare provider based in Union City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2020. The National Provider Identifier (NPI) number assigned to this provider is 1447870449.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chelsea Shannon, FNP-BC has received a total of $572.80 in payments from pharmaceutical and medical device companies, with $31.86 received in 2024. These payments were reported across 32 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($572.80).
As a Medicare-enrolled provider, Shannon has provided services to 733 Medicare beneficiaries, totaling 889 services with total Medicare billing of $35,745. Data is available for 3 years (2021–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Union City, TN
- Active Since 04/20/2020
- Last Updated 07/06/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1447870449
Products in Payments
- QULIPTA (Drug) $78.39
- RYBELSUS (Drug) $73.58
- Rybelsus (Drug) $57.56
- PREVNAR 20 (Biological) $53.94
- MOUNJARO (Drug) $50.80
- Saxenda (Drug) $44.03
- VRAYLAR (Drug) $36.10
- UBRELVY (Drug) $32.72
- TRULICITY (Drug) $28.03
- Wegovy (Drug) $23.06
- Ozempic (Drug) $18.68
- BOTOX (Biological) $18.14
- ENTRESTO (Drug) $17.63
- GARDASIL 9 (Biological) $17.05
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Union City
Yanet Rivas
Family — Payments: $10,797
Laura Russell, Cfnp, CFNP
Family — Payments: $5,430
Ms. Bernadette Ramos, Apn, APN
Family — Payments: $5,151
Brenda Dexter, Fnp C, FNP C
Family — Payments: $4,920
Amy Myers, Cfnp, CFNP
Family — Payments: $4,698
Rita Koon, Fnp Bc, FNP BC
Family — Payments: $3,936